ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 432,36
0,15%
Dow Jones
43 914,12
-0,53%
DAX
20 478,19
0,24%
Brent Oil
73,565
0,48%
Bitcoin
99 960,96
-0,10%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Newcourt Acquisition Corporation (NCAC) Cours

Newcourt Acquisition Corporation

Newcourt Acquisition Corporation (NCAC)

NASDAQ
4,79
0,00
(0,00%)
Fermé 13 Décembre 10:00PM
Retardé de 15 minutes
4,79
0,00
( 0,00% )
Avant marché: 1:00AM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
4,79
Prix Achat
4,73
Prix Vente
4,90
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
4,79
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

NCAC Dernières nouvelles

Plus de nouvelles

Newcourt Acquisition Corp Announces Continuation of Business Combination Close Process

NEW YORK, NY, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Newcourt Acquisition Corp (“Newcourt”) (NASDAQ: NCAC) announced today that the conditions to closing the business combination (the “Business...

23 Janvier 2024
GlobeNewswire Inc.

Psyence Group Inc Subsidiary Psyence Biomedical Ltd. announces signing of definitive agreement for a convertible note in connection with planned business combination

TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc ("Psyence Group") (CSE:PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in...

16 Janvier 2024
GlobeNewswire Inc.

Psyence Group Announces SEC Effectiveness of F-4 for Proposed Business Combination Between Subsidiary and Nasdaq Listed Newcourt Acquisition Corp

TORONTO, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE:PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and...

15 Novembre 2023
GlobeNewswire Inc.

Psyence Group Announces SEC Registration Filing with NASDAQ SPAC, Newcourt, and Signing of Amended and Restated Business Combination Agreement

VANCOUVER, British Columbia, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE:PSYG | OTCQB: PSYGF), a clinical-stage life science biotechnology company pioneering the use of natural...

02 Août 2023
GlobeNewswire Inc.

Newcourt Acquisition Corp Announces Amendment and Supplement to its Definitive Proxy Statement

New York, NY, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Newcourt Acquisition Corp (the “Company”) (NASDAQ: NCAC) announced today that the Company has determined to modify the terms of the proposed...

30 Décembre 2022
GlobeNewswire Inc.

Newcourt Acquisition Corp Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing December 10, 2021

New York, NY, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Newcourt Acquisition Corp (the “Company”) (NASDAQ: NCACU) announced today that, commencing December 10, 2021, holders of the units sold in the...

09 Décembre 2021
GlobeNewswire Inc.

Newcourt Acquisition Corp Announces Closing of Upsized $250 Million Initial Public Offering Including Partial Exercise of Over-Allotment Option

New York, NY, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Newcourt Acquisition Corp (the “Company”), a newly incorporated blank check company, today announced the closing of its upsized initial public...

22 Octobre 2021
GlobeNewswire Inc.

Newcourt Acquisition Corp Announces Pricing of Upsized $220 Million Initial Public Offering

New York, NY, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Newcourt Acquisition Corp (the “Company”) announced today that it priced its upsized initial public offering of 22,000,000 units at $10.00 per...

20 Octobre 2021
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
PRLHPearl Holdings Acquisition Corporation
US$ 42,00
(256,23%)
11,18k
SPISPI Energy Company Ltd
US$ 0,5104
(45,83%)
6,3M
LOOPLoop Industries Inc
US$ 1,70
(38,21%)
1,44M
LICNLichen China Limited
US$ 0,25505
(30,19%)
1,57M
SHPHShuttle Pharmaceuticals Holdings Inc
US$ 0,90
(28,57%)
1
RPTXRepare Therapeutics Inc
US$ 2,54
(-36,02%)
19,35k
CADLCandel Therapeutics Inc
US$ 6,78
(-30,82%)
134,32k
PROVProvident Financial Holdings Inc
US$ 13,00
(-20,63%)
100
INOInovio Pharmaceuticals Inc New
US$ 3,04
(-19,15%)
425
ACTUActuate Therapeutics Inc
US$ 7,00
(-15,56%)
201
SPISPI Energy Company Ltd
US$ 0,512
(46,29%)
6,29M
LICNLichen China Limited
US$ 0,2563
(30,83%)
1,54M
LOOPLoop Industries Inc
US$ 1,66
(34,96%)
1,43M
LAESSEALSQ Corporation
US$ 1,65
(-10,81%)
1,33M
TRUGTruGolf Holdings Inc
US$ 0,6301
(21,43%)
1,02M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
NCAC
Newcourt Acquisition
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés